title: TP53 mutation and microsatellite instability status for the prediction of survival in adjuvant-treated colon cancer patients.
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Watanabe
authors.forename: Takamitsu
authors.initials: T
authors.lastname: Kanazawa
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Kazama
authors.forename: Junichiro
authors.initials: J
authors.lastname: Tanaka
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Tanaka
authors.forename: Soichiro
authors.initials: S
authors.lastname: Ishihara
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Nagawa
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D004252:DNA Mutational Analysis; D018572:Disease-Free Survival; D005472:Fluorouracil / Q000627:therapeutic use; D016158:Genes, p53 / Q000235:genetics*; D011905:Genes, ras / Q000235:genetics*; D042822:Genomic Instability; D006801:Humans; D018895:Microsatellite Repeats / Q000235:genetics*; D009367:Neoplasm Staging; D011379:Prognosis; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil